Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
Introduction: Cerebral venous thrombosis (CVT) is a life-threatening neurological condition. There is limited evidence for the use of direct oral anticoagulants (DOAC) for long-term anticoagulation in this patient population. We report a case series of patients treated with apixaban and their clinic...
Main Authors: | Suman Preet Bharath MD, Hasnain Arshad MD, Yong-Bum Song Pharm D, Jawad F. Kirmani MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296221129591 |
Similar Items
-
CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
by: I. S. Yavelov
Published: (2015-12-01) -
ORAL ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS: FOCUS ON APIXABAN
by: M. Yu. Gilyarov, et al.
Published: (2017-12-01) -
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
by: Setareh Salehi Omran, et al.
Published: (2023-05-01) -
Anticoagulation complications in a patient with prior cerebral venous thrombosis
by: Ioana Cociasu, et al.
Published: (2015-06-01) -
Long term anticoagulant therapy with varfarin efficacy and safety in patients with venous thrombosis
by: T Y Kozlova
Published: (2005-08-01)